Literature DB >> 25209928

Etanercept in the treatment of SAPHO syndrome.

Luis-Carlos Sáez-Martín1, Susana Gómez-Castro2, Concepción Román-Curto3, Irene Palacios-Álvarez3, Emilia Fernández-López3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25209928     DOI： 10.1111/ijd.12675

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  3 in total

Review 1.  Clinical heterogeneity of SAPHO syndrome: challenging diagnose and treatment.

Authors:  Francesco Cianci; Angelo Zoli; Elisa Gremese; Gianfranco Ferraccioli
Journal:  Clin Rheumatol       Date:  2017-07-19       Impact factor: 2.980

2.  [SAPHO syndrome : An overview and nosological differentiation of 35 disease cases].

Authors:  Philipp Klemm; Uwe Lange
Journal:  Z Rheumatol       Date:  2021-03-16       Impact factor: 1.372

Review 3.  New Insights in the Treatment of SAPHO Syndrome and Medication Recommendations.

Authors:  Wei Cheng; Fen Li; Jing Tian; Xi Xie; Jin-Wei Chen; Xiao-Fei Peng; Qi Tang; Yan Ge
Journal:  J Inflamm Res       Date:  2022-04-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.